21346177|hyperuricemia|C0740394|start=0|end=13|DISO
21346177|endocrine|C0521425^C0553665^C0014136|start=51|end=60|DISO^CONC^ANAT
21346177|imbalance|C1397014|start=61|end=70|DISO
21346177|adipose tissue|C0001527|start=78|end=92|ANAT
21346177|model|C0026336^C3714583^C3274659^C0026339^C3161035|start=105|end=110|DEVI^CONC
21346177|metabolic syndrome|C0524620|start=118|end=136|DISO
21346177|objective|C0018017^C1571702^C2979883|start=138|end=147|PHYS^CONC
21346177|hyperuricemia|C0740394|start=149|end=162|DISO
21346177|associated with|C0332281|start=175|end=190|CONC
21346177|obesity|C0028754|start=191|end=198|DISO
21346177|metabolic syndrome|C0524620|start=203|end=221|DISO
21346177|visceral obesity|C2936179|start=238|end=254|DISO
21346177|insulin resistance|C2700570^C0021655|start=259|end=277|DISO^GENE
21346177|soluble|C1749467^C1948047|start=306|end=313|ANAT^CONC
21346177|uric acid|C0202239|start=314|end=323|PROC
21346177|directly|C1947931|start=324|end=332|CONC
21346177|stimulated|C1948023|start=333|end=343|PHEN
21346177|redox|C0030012|start=348|end=353|PHYS
21346177|dependent|C3244310^C1701901^C0851827|start=354|end=363|CONC
21346177|signaling|C3537152^C0037083|start=380|end=389|PHEN^PHYS
21346177|adipocytes|C0206131|start=393|end=403|ANAT
21346177|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=413|end=418|PROC^OBJC^CONC
21346177|role|C1705809^C0035820^C1705812^C1704326^C1705811^C1705810|start=438|end=442|ACTI^CONC
21346177|hyperuricemia|C0740394|start=446|end=459|DISO
21346177|production|C0033268|start=467|end=477|ACTI
21346177|key|C1554080^C1706198|start=481|end=484|CONC
21346177|research design|C0035171|start=497|end=512|PROC
21346177|methods|C0025664^C0449851^C0025663|start=517|end=524|CONC
21346177|adipocytes|C0206131|start=547|end=557|ANAT
21346177|primary|C0205225^C0439631|start=565|end=572|PROC^CONC
21346177|adipocytes|C0206131|start=573|end=583|ANAT
21346177|mouse model|C2986594|start=591|end=602|DISO
21346177|metabolic syndrome|C0524620|start=606|end=624|DISO
21346177|hyperuricemia|C0740394|start=629|end=642|DISO
21346177|uric acid|C0202239|start=653|end=662|PROC
21346177|induced|C0205263|start=663|end=670|CONC
21346177|in vitro|C1533691^C2827718^C0021135|start=671|end=679|CONC
21346177|increase|C0442805|start=683|end=691|CONC
21346177|production|C0033268|start=699|end=709|ACTI
21346177|secreted|C1327616|start=720|end=728|PHYS
21346177|protein|C0555903^C1521746|start=729|end=736|PROC^CONC
21346177|monocyte|C0026473|start=741|end=749|ANAT
21346177|protein|C0555903^C1521746|start=762|end=769|PROC^CONC
21346177|mcp|C1150292^C1824669^C3540820^C1413108|start=773|end=776|GENE^PHYS
21346177|playing|C0032214|start=794|end=801|ACTI
21346177|essential|C0205224|start=805|end=814|CONC
21346177|role|C1705809^C0035820^C1705812^C1704326^C1705811^C1705810|start=815|end=819|ACTI^CONC
21346177|inducing|C0205263|start=823|end=831|CONC
21346177|state|C1552743^C1301808^C3148680^C1442792|start=852|end=857|GEOG^ORGA^CONC
21346177|adipocytes|C0206131|start=861|end=871|ANAT
21346177|obesity|C0028754|start=875|end=882|DISO
21346177|addition|C0332287^C1883712|start=887|end=895|CONC
21346177|uric acid|C0202239|start=897|end=906|PROC
21346177|decrease|C0392756^C0547047|start=916|end=924|CONC
21346177|production|C0033268|start=932|end=942|ACTI
21346177|adiponectin|C2700366^C2986675^C1540187|start=946|end=957|PROC^GENE
21346177|adipocyte|C0206131|start=962|end=971|ANAT
21346177|specific|C0205369^C1552740|start=972|end=980|CONC
21346177|insulin|C0202098^C1337112^C2739803|start=981|end=988|PROC^GENE^PHYS
21346177|anti-inflammatory|C1515999|start=1004|end=1021|CONC
21346177|agent|C1521826|start=1022|end=1027|CONC
21346177|uric acid|C0202239|start=1029|end=1038|PROC
21346177|induced|C0205263|start=1039|end=1046|CONC
21346177|increase|C0442805|start=1047|end=1055|CONC
21346177|mcp|C1150292^C1824669^C3540820^C1413108|start=1059|end=1062|GENE^PHYS
21346177|production|C0033268|start=1065|end=1075|ACTI
21346177|blocked|C0028778^C0332206|start=1080|end=1087|DISO^CONC
21346177|inhibiting|C3463820|start=1119|end=1129|ACTI
21346177|nadph oxidase|C1151146|start=1130|end=1143|PHYS
21346177|stimulating|C1948023|start=1151|end=1162|PHEN
21346177|peroxisome|C0752063^C2984308|start=1163|end=1173|ANAT^CONC
21346177|activated|C1879547|start=1187|end=1196|ACTI
21346177|gamma|C1552644^C1823153^C0017011^C2349976|start=1206|end=1211|GENE^PHEN^CONC
21346177|downregulation|C0013081|start=1232|end=1246|PHYS
21346177|adiponectin|C2700366^C2986675^C1540187|start=1254|end=1265|PROC^GENE
21346177|production|C0033268|start=1266|end=1276|ACTI
21346177|obese|C0028754|start=1336|end=1341|DISO
21346177|mice|C1413131^C1417166|start=1342|end=1346|GENE
21346177|metabolic syndrome|C0524620|start=1352|end=1370|DISO
21346177|observed|C1441672|start=1375|end=1383|CONC
21346177|hyperuricemia|C0740394|start=1384|end=1397|DISO
21346177|lowering|C0441994^C2003888|start=1399|end=1407|ACTI^CONC
21346177|uric acid|C0202239|start=1408|end=1417|PROC
21346177|mice|C1413131^C1417166|start=1427|end=1431|GENE
21346177|inhibiting|C3463820|start=1435|end=1445|ACTI
21346177|xanthine oxidoreductase|C1421531|start=1446|end=1469|GENE
21346177|endocrine|C0521425^C0553665^C0014136|start=1521|end=1530|DISO^CONC^ANAT
21346177|imbalance|C1397014|start=1531|end=1540|DISO
21346177|adipose tissue|C0001527|start=1548|end=1562|ANAT
21346177|reducing|C0392756|start=1566|end=1574|CONC
21346177|production|C0033268|start=1575|end=1585|ACTI
21346177|mcp|C1150292^C1824669^C3540820^C1413108|start=1589|end=1592|GENE^PHYS
21346177|increasing|C0442808|start=1599|end=1609|CONC
21346177|production|C0033268|start=1610|end=1620|ACTI
21346177|adiponectin|C2700366^C2986675^C1540187|start=1624|end=1635|PROC^GENE
21346177|addition|C0332287^C1883712|start=1640|end=1648|CONC
21346177|lowering|C0441994^C2003888|start=1650|end=1658|ACTI^CONC
21346177|uric acid|C0202239|start=1659|end=1668|PROC
21346177|obese|C0028754|start=1672|end=1677|DISO
21346177|mice|C1413131^C1417166|start=1678|end=1682|GENE
21346177|decreased|C0392756^C0205216^C0442797|start=1683|end=1692|CONC
21346177|macrophage|C0024432|start=1693|end=1703|ANAT
21346177|infiltration|C3669041^C0332448^C1523986^C0702249|start=1704|end=1716|DISO^PROC^CONC
21346177|adipose tissue|C0001527|start=1724|end=1738|ANAT
21346177|reduced|C0392756|start=1743|end=1750|CONC
21346177|insulin resistance|C2700570^C0021655|start=1751|end=1769|DISO^GENE
21346177|conclusions|C1707478|start=1771|end=1782|CONC
21346177|hyperuricemia|C0740394|start=1784|end=1797|DISO
21346177|endocrine|C0521425^C0553665^C0014136|start=1853|end=1862|DISO^CONC^ANAT
21346177|imbalance|C1397014|start=1863|end=1872|DISO
21346177|adipose tissue|C0001527|start=1880|end=1894|ANAT
21346177|mechanism|C1706376^C0441712|start=1919|end=1928|OBJC^CONC
21346177|inflammation|C0021368|start=1946|end=1958|DISO
21346177|insulin resistance|C2700570^C0021655|start=1963|end=1981|DISO^GENE
21346177|metabolic syndrome|C0524620|start=2003|end=2021|DISO
